Dr. Falk Pharma GmbH (“Dr. Falk Pharma”), a research-based pharmaceutical company specializing in digestive and metabolic medicine, and Renexxion Ireland Limited (“Renexxion”), a clinical-stage ...

FGID occurs due to the abnormal functioning of the GI tract. A recent study indicated that around 40% of the world's population is affected by FGID. 2 In comparison to men, women are more commonly ...

If your IBS symptoms never quite add up, it might be because your gut is juggling more than one problem at once. If you have ...

Digestive disorders and fatty liver are rising among teens due to poor lifestyle habits. Expert warns how diet, stress, and ...

Wine may cause discomfort for people with gastrointestinal disorders, new research suggests. Though some evidence conflicts, studies lean toward wine causing negative effects for those with GI ...

According to Precedence Research, the global digestive health products market size is estimated to reach nearly USD 290.31 ...

Add gastrointestinal problems to the long list of lingering conditions that can follow COVID-19. New research has found that people who have had COVID-19 are at an increased risk of gastrointestinal ...

Today's generation of young adults is at the turning point of success and failure. Modern times make things easier but also ...

LONDON--(BUSINESS WIRE)--By 2017 the gastrointestinal disorder therapeutics market is expected to be worth $18.3 billion by 2017, according to a new report available on companiesandmarkets.com.

Background and Aim Allergies have been implicated in the pathogenesis of eosinophilic gastrointestinal disorders, although it remains unknown what type of allergen is closely associated with their ...